Updates are available Correction dated 2025-02-20
Click to view Correction: https://doi.org/10.1186/s41983-025-00940-1
-
Authors
Khedr, Eman M.
Elbassiouny, Ahmed
Nageeb, Mahmoud
Aly, Ahmed
Mohamed, Khalid O.
Haridy, Nourelhoda A.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05091320 at ClinicalTrials.govDocuments that mention this clinical trial
Outcomes and safety of mechanical thrombectomy, alteplase, and conventional medical care in the treatment of acute M2 segment middle cerebral artery occlusion: a comparative study
https://doi.org/10.1186/s41983-025-00935-y
Common design and data elements reported in active mechanical thrombectomy trials focusing on distal medium vessel occlusions and minor strokes: a systematic review
https://doi.org/10.1136/jnis-2023-021073
Influence of prior intravenous thrombolysis in patients treated with mechanical thrombectomy for M2 occlusions: insight from the Endovascular Treatment in Ischemic Stroke (ETIS) registry
https://doi.org/10.1136/jnis-2022-019672
- License Information
-
More Information
Article History
Received: 12 October 2024
Accepted: 18 January 2025
First Online: 30 January 2025
Change Date: 20 February 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s41983-025-00940-1
Declarations
:
: The study was approved by the Assiut University, Faculty of Medicine’s ethical committee and registered with the Institutional Review Board (IRB no: 17200628). The clinical trial was registered on ClinicalTrials.gov (NCT05091320). The research adhered to the ethical principles outlined in the World Medical Association's Declaration of Helsinki. Written informed consent was obtained from patients or relatives after explaining all study aspects and potential risks.
: Not applicable.
: The authors declare no competing interests.
